CAS: 1097917-15-1 - ASP-3026
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
CAS:1097917-15-1
Formula:
C29H40N8O3S
Purity:
%
Color and Shape:
Solid
Molecular weight:
580.7447
Ref: IN-DA008TDJ
5mg | 56.00 € | ||
10mg | 73.00 € | ||
100mg | 258.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
ASP3026
CAS:1097917-15-1
ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced …
Formula:
C29H40N8O3S
Purity:
98.78% - ≥95%
Color and Shape:
Solid
Molecular weight:
580.74
Ref: TM-T1962
5mg | 37.00 € | ||
10mg | 50.00 € | ||
25mg | 83.00 € | ||
50mg | 113.00 € | ||
100mg | 181.00 € | ||
200mg | 268.00 € | ||
1mL*10mM (DMSO) | 79.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
ASP3026
CAS:1097917-15-1
ASP3026 is a potent anti-tumor agent that binds to the epidermal growth factor receptor (EGFR) …
Formula:
C29H40N8O3S
Purity:
Min. 95%
Molecular weight:
580.75 g/mol
Ref: 3D-XTB91715
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025